Selventa

Selventa Granted Patent for Discovery of Biomarker Profiles

Selventa Granted Patent for Discovery of Biomarker Profiles

January 23, 2012

CAMBRIDGE, Mass., Jan 23, 2012 (BUSINESS WIRE) -- Selventa(TM), a biomarker discovery company that enables personalized healthcare through stratification of patients based on disease-driving mechanisms, today announced that the U.S. Patent & Trademark Office has issued the Company U.S.

Joule Unlimited, Inc.

Joule Prepares for Global Deployment with Appointment of Proven Industry Experts to Lead Commercial Operations

Joule Prepares for Global Deployment with Appointment of Proven Industry Experts to Lead Commercial Operations

January 23, 2012

Bedford, Mass. – January 23, 2012 – Joule today announced the appointment of two key executives to manage the company's roll-out of renewable fuel production facilities worldwide. Peter Erich has joined as Executive Vice President, General Manager Commercial Operations, and will lead the team responsible for site development and technology deployment. Paul Snaith has been appointed to build and manage the related partnerships as Head of Business Development & Strategy.

Tetraphase Pharmaceuticals, Inc.

Tetraphase Appoints L. Patrick Gage, Ph.D., as Chairman of the Board

Tetraphase Appoints L. Patrick Gage, Ph.D., as Chairman of the Board

January 18, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc., a clinical-stage life science company developing a portfolio of potent new antibiotics, today announced that L. Patrick “Pat” Gage, Ph.D., biopharmaceutical industry pioneer, has been appointed as the company’s Chairman of the Board. In this role, Dr.

Affinnova, Inc.

Affinnova Helps Sbarro Serve up an Optimized Pricing Strategy

Affinnova Helps Sbarro Serve up an Optimized Pricing Strategy

January 18, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Facing rising food costs and softening industry traffic, Sbarro, the world’s leading Italian quick service restaurant, turned to Affinnova, Inc., the global leader in marketing innovation software and services, to help strategically optimize its menu pricing. Understanding that traditional point-of-sale tracking data would not provide enough guidance, Sbarro used Affinnova’s technology to perform a holistic review of its pricing strategy. 

Novomer, Inc.

Novomer and Penford Enter into Joint Development Agreement

Novomer and Penford Enter into Joint Development Agreement

January 17, 2012

Boston, Mass. – January 17, 2012 – Novomer Inc., a new materials company pioneering a family of high-performance plastics and polymers using renewable feedstocks such as carbon dioxide, and Penford Corporation, a company with significant business and expertise in specialty starches and sustainable bio-products  announce that they have entered into a Joint Development Agreement that will leverage the two companies’ core technologies and expertise.

AeroDesigns Inc.

Breathable Foods® Announces the Retail Launch of AeroShot Pure Energy™

Breathable Foods® Announces the Retail Launch of AeroShot Pure Energy™

January 17, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Breathable Foods announces the official launch of AeroShot Pure Energy in Boston and New York where it is now available to purchase in retail outlets. AeroShot is a first-of-its-kind, calorie-free breathable energy product that delivers an airborne shot of caffeine through a pocket-sized, single-use device. Offering consumers a unique way to get their caffeine, as little or as much as they need when they need it, this innovative supplement is revolutionizing the way people energize their lives.

Joule Unlimited, Inc.

JOULE SECURES $70M IN PRIVATE EQUITY INVESTMENTS FOR GROWTH

JOULE SECURES $70M IN PRIVATE EQUITY INVESTMENTS FOR GROWTH

January 17, 2012

WORLD FUTURE ENERGY SUMMIT – Abu Dhabi, UAE – January 17, 2012 – Joule today announced the closing of a $70 million third round of funding, supporting its aggressive timeline to commercialization and bringing its total to $110+ million raised to date. The round included investments from both new and prior undisclosed institutional and private sources that joined Flagship Ventures, Joule’s founding venture capital investor. The news was released in conjunction with Joule’s participation at the World Future Energy Summit, where President and CEO William J.

‘Beating heart’ transplants could boost success rate

‘Beating heart’ transplants could boost success rate

January 11, 2012

Amy DeStefano was a single mother juggling family life and a full-time job three winters ago when she caught what at first was just a persistent February cold. Then it spiraled into pneumonia and spread to her heart.
 
By last January, DeStefano, at 39, was on the waiting list for a heart transplant at Massachusetts General Hospital.
 
Her wait ended late last month when the social worker from Portsmouth, N.H., became the first patient in New England to receive an experimental “beating heart’’ transplant.

Receptos, Inc.

Receptos Achieves Milestone Under License of G-Protein Coupled Receptor Crystal Structure Determination Technology

Receptos Achieves Milestone Under License of G-Protein Coupled Receptor Crystal Structure Determination Technology

January 10, 2012

SAN DIEGO, Jan. 10, 2012 -- Receptos Inc. today announced the successful achievement of the technology transfer milestone under its license and technology transfer deal with Janssen Pharmaceuticals, Inc. (formerly Ortho-McNeil Janssen Pharmaceuticals, Inc.), for Receptos' breakthrough GPCR crystal structure determination technology.

FLAGSHIP VENTURES CLOSES $270 MILLION EARLY-STAGE VENTURE CAPITAL FUND

FLAGSHIP VENTURES CLOSES $270 MILLION EARLY-STAGE VENTURE CAPITAL FUND

January 11, 2012

Cambridge, Mass. – Jan. 11, 2012 – Flagship Ventures, a leading venture capital firm focused on healthcare and sustainability, today announced the year-end 2011 close of its largest fund to date, raising $270 million for Flagship Ventures Fund IV L.P., exceeding its target of $250 million. Investors in Flagship Ventures Fund IV include pension funds, foundations, fund-of-funds, corporations and individuals. Joining prior fund investors were several new limited partners.